Blog

Selecta taps Ginkgo for deal worth up to $1.1B

scientists-01900xx6720-4480-0-0

Selecta Biosciences Inc. has chosen Ginkgo Bioworks Holdings Inc. to develop new viral capsids for gene therapies.

Read More